A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.

Four Switches of Success

Very similar firms often achieve very different results This is explained by their genetic switches..

The Future of Pharma Regulations

The future of pharma regulations is challenging with diverse and complex regulations globally It will be challenging for industry to adapt to regulated and semiregulated markets alike while attempting to develop a harmonised strategy with evergrowing cost pressure on offpatent products for both smal..

Rigour or Rigmarole

All companies plan to succeed but only a few succeed in planning The differences between them lie in how they answer seven fundamental questions..

Analytical Characterisations of Bio-Similar Products and Peptide-based Drugs

Biosimilars can exhibit tremendous heterogeneity in terms of structural and posttranslational modifications Therefore comprehensive characterisation of biosimilars is necessary to ensure safety and efficacy The analytical tests to demonstrate similarity of a biosimilar product to a reference drug wi..

Decision-making in Vaccines

How the fusion of price with access risks a tragedy of the commons

If we are to maintain a healthy global market for vaccines RD and production as well as optimising its benefit to mankind those taking public health and financial decisions about vaccinations must have access to the expertise that will prevent them from taking pricing and procurement decisions that ..

State of Pharmacovigilance

Proposals for streamlining the system

In recent years there has been a proliferation of pharmacovigilance guidelines and regulations Regulatory authorities have implemented different requirements templates and regulations and some of them have asked pharmaceutical companies to produce many documents with overlapping content These requir..

Growing the Regenerative Medicine Industry in Asia-Pacific with Help from Regulatory Science

Regenerative medicine RM is a gamechanging area of medicine with the potential to bring products that incorporate a viable cellular component intended to repair replace or restore diseased damaged or missing tissues into the marketplace However because most RM products represent breakthroughs in med..

The Genetically Modified Organisation

New research points to how leaders can accelerate their firm’s evolution

To paraphrase Darwin it is not the strongest nor most intelligent life science company that will survive it is the one most able to change Yet many companies find it very difficult to change in ways that preserves the best of the corporate DNA whilst adapting to the changes in our technological poli..

Competing on Alignment

SWOT is both the most powerful and least understood strategic management tool Used correctly it translates the outputs of many other market analyses into a small number of key issues..

Sustainable Antibiotics

Evolving pharmaceutical supply chain to ensure effectiveness

Principles of product stewardship have to be applied to make sure that from production through to use and disposal along the entire supply and value chain antibiotics are not just delivering positive direct benefits to patients but deliver positive benefits to society overall..